Milk and Soured Milk (filmjölk) Intervention on Oxidative Stress and Inflammation
1 other identifier
interventional
84
1 country
1
Brief Summary
This study evaluates a high intake of milk compared with a high intake of soured milk (Swedish filmjölk) on markers of oxidative stress and inflammation in a randomized crossover intervention study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2019
CompletedFirst Submitted
Initial submission to the registry
January 16, 2019
CompletedFirst Posted
Study publicly available on registry
January 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2020
CompletedNovember 4, 2020
November 1, 2020
1.4 years
January 16, 2019
November 3, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Change in oxidative stress marker
urinary 8-iso-prostaglandin F2 alpha (8-iso-PGF2alpha)
baseline and 3 weeks
Change in oxidative stress marker
urinary 8-iso-prostaglandin F2 alpha (8-iso-PGF2alpha)
6 weeks and 9 weeks
Secondary Outcomes (6)
Change in interleukin-6 (IL-6)
baseline and 3 weeks
Change in interleukin-6 (IL-6)
6 weeks and 9 weeks
Change high sensitive C-reactive protein (hs-CRP)
baseline and 3 weeks
Change high sensitive C-reactive protein (hs-CRP)
6 weeks and 9 weeks
Change in 15-keto-dihydro-prostaglandin F2 alpha (15-keto-dihydro-PGF2alpha)
baseline and 3 weeks
- +1 more secondary outcomes
Study Arms (2)
Milk
EXPERIMENTALAt least 500 ml of Swedish milk daily for three weeks (crossover). Intervention and crossover preceded by 3 weeks with max 50 ml of milk or soured milk (filmjölk) daily. Fat content of milk and soured milk should be the same: 0.5%, 1.5% or 3%.
Soured milk (filmjölk)
EXPERIMENTALAt least 500 ml of Swedish soured milk (filmjölk) daily for three weeks (crossover). Intervention and crossover preceded by 3 weeks with max 50 ml of milk or soured milk (filmjölk) daily. Fat content of milk and soured milk should be the same: 0.5%, 1.5% or 3%.
Interventions
Eligibility Criteria
You may qualify if:
- Tolerates both a low and a high intake of milk and soured milk
- Agrees to comply with study protocol
You may not qualify if:
- Inflammatory bowel disease
- Major gastric tract operation
- Pregnancy
- Eating disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uppsala Universitylead
- Fortecollaborator
Study Sites (1)
Forskningsmottagning bentäthet, Kirurgiska vetenskaper, Uppsala Universitet
Uppsala, 75185, Sweden
Related Publications (4)
Larsson SC, Crippa A, Orsini N, Wolk A, Michaelsson K. Milk Consumption and Mortality from All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis. Nutrients. 2015 Sep 11;7(9):7749-63. doi: 10.3390/nu7095363.
PMID: 26378576BACKGROUNDMichaelsson K, Wolk A, Langenskiold S, Basu S, Warensjo Lemming E, Melhus H, Byberg L. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014 Oct 28;349:g6015. doi: 10.1136/bmj.g6015.
PMID: 25352269BACKGROUNDTognon G, Nilsson LM, Shungin D, Lissner L, Jansson JH, Renstrom F, Wennberg M, Winkvist A, Johansson I. Nonfermented milk and other dairy products: associations with all-cause mortality. Am J Clin Nutr. 2017 Jun;105(6):1502-1511. doi: 10.3945/ajcn.116.140798. Epub 2017 May 10.
PMID: 28490510BACKGROUNDHolloway KL, Bucki-Smith G, Morse AG, Brennan-Olsen SL, Kotowicz MA, Moloney DJ, Sanders KM, Korn S, Timney EN, Dobbins AG, Pasco JA. Humeral Fractures in South-Eastern Australia: Epidemiology and Risk Factors. Calcif Tissue Int. 2015 Nov;97(5):453-65. doi: 10.1007/s00223-015-0039-9. Epub 2015 Jul 14.
PMID: 26169198BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liisa Byberg, PhD
Department of Surgical Sciences, Uppsala University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2019
First Posted
January 29, 2019
Study Start
January 7, 2019
Primary Completion
June 9, 2020
Study Completion
June 9, 2020
Last Updated
November 4, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share